Five months into his tenure as Secretary of Health and Human Services (HHS), Robert F. Kennedy Jr. has set his sights on a quiet but critical pillar of the American public health system: the Vaccine Injury Compensation Program (VICP). While obscure to the general public, this program has played a foundational role in preserving vaccine access in the United States since its inception in the 1980s.
Kennedy, known for his long-standing opposition to vaccines, now holds the power to reshape or even dismantle the very system designed to ensure vaccines remain widely available and safe. Experts warn that such changes could unravel the entire U.S. immunization infrastructure, potentially leading to catastrophic public health consequences.
What is the Vaccine Injury Compensation Program?
The VICP was created in 1986 amid a liability crisis. At the time, vaccine manufacturers were fleeing the market due to a surge of lawsuits claiming severe side effects from childhood vaccines. To stabilize the supply of vaccines, Congress passed a bipartisan law establishing the VICP, a no-fault compensation system that protects manufacturers from most civil lawsuits while ensuring fair payouts to people injured by vaccines.
Funded by a 75-cent tax on each vaccine dose, the program pays for injuries deemed scientifically plausible, such as anaphylaxis or Guillain-Barré syndrome. It allows injured parties to bypass traditional courts and receive compensation through a specialized vaccine court. While the system isn’t perfect, it has paid out approximately $4.8 billion since its inception and is credited with sustaining the viability of vaccine development in the U.S.
Kennedy’s Critique and Plans for Overhaul
RFK Jr. has long argued that the VICP eliminates accountability for pharmaceutical companies, thereby reducing incentives to make safer vaccines. In a recent interview with Tucker Carlson, Kennedy criticized the program’s inner workings, accusing Department of Justice lawyers of prioritizing the protection of the fund over justice for the injured.
Kennedy has indicated a desire to broaden eligibility for compensation, expand the program’s statute of limitations, and potentially add more medical conditions such as autism, diabetes, ADHD, and even eczema to the list of injuries covered by the program. While he hasn’t provided detailed plans, these changes could destabilize the VICP and strain its $4.8 billion trust fund.
Kennedy’s suggestion that vaccines may cause autism and a host of chronic ailments contradicts decades of robust scientific research. Numerous large-scale studies and legal reviews have found no link between vaccines and autism. The vaccine court itself dismissed thousands of autism-related claims after extensive hearings and testimony.
Despite this, Kennedy’s role as HHS Secretary gives him considerable influence. He could, through the federal rulemaking process, add new conditions to the injury table, thereby dramatically increasing the number of claims and payouts.
The Fragile State of Vaccine Manufacturing
The United States’ vaccine infrastructure is already precariously concentrated. Just a few manufacturers supply most routine childhood vaccines. If Kennedy’s reforms open the floodgates to civil lawsuits or bankrupt the compensation fund, these companies could again consider exiting the U.S. market just as they did in the 1980s.
Dr. Paul Offit, a vaccine developer and longtime Kennedy critic, warns that “adding conditions like autism to the injury table based on flawed or cherry-picked science could bankrupt the program.” Similarly, Dorit Reiss, a legal expert on vaccine law, notes that Congress might then have to intervene either by increasing the vaccine tax, restricting the injury table, or possibly abolishing the program altogether.
Kennedy has already taken steps to remake the VICP from the inside. He appointed Andrew Downing, a lawyer who has represented numerous VICP claimants, as a counselor at HHS. Downing’s law firm recently secured a government contract for vaccine injury expertise. While legal, this relationship raises ethical questions about the direction and intent of Kennedy’s overhaul.
Further complicating matters, Kennedy previously referred clients to a law firm litigating against Merck over its HPV vaccine, in exchange for a 10% referral fee, a portion of which he later claimed would go to his son. The arrangement drew scrutiny during his confirmation hearings, especially from Senator Elizabeth Warren.
The American Academy of Pediatrics and several other medical groups recently filed a lawsuit against Kennedy, accusing him of dismantling the “science-based vaccine infrastructure” responsible for preventing millions of deaths. The groups are alarmed not just by his rhetoric but by concrete actions such as firing the federal vaccine advisory board and halting global vaccine aid.
These changes come amid the resurgence of vaccine-preventable diseases. Measles, eliminated in the U.S. in 2000, has now returned with more cases than in the past three decades—including three deaths this year.
The VICP was born from crisis and helped usher in an era of vaccine innovation and stability. Kennedy’s proposed reforms, if implemented could return the U.S. to a state of legal chaos and medical scarcity, endangering decades of progress in public health.
Though some parts of the program could benefit from modernization, many in the scientific and legal communities fear Kennedy’s approach could tip the system into collapse. As vaccine supply hangs in the balance, the next steps taken by the HHS Secretary may determine the future of immunization in America.
